Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Aduro Biotech Q1 EPS $(0.090) Up From $(0.290) YoY, Sales $13.950M Up From $3.938M YoY

Author: Benzinga Newsdesk | May 04, 2020 04:28pm
Aduro Biotech (NASDAQ:ADRO) reported quarterly losses of $(0.090) per share. This is a 68.97 percent increase over losses of $(0.290) per share from the same period last year. The company reported $13.950 million in sales this quarter. This is a 254.24 percent increase over sales of $3.938 million the same period last year.

Posted In: ADRO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist